ArticlePLoS biology2021
Addressing the environmental and health impacts of microplastics requires open collaboration between diverse sectors.
Article in PLoS biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 77 citations in OpenAlex.
- The effects of microplastics exposure on the growth and development of children.Frontiers in public health · 2026Review
- Harmfulness Score: A Data-Driven Framework for Ranking Environmental Risks of Microplastics.Macromolecular rapid communications · 2025Article
- Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers.Molecular cancer · 2025Review
- Review
- Review
- Violet Innovation Grade Index (VIGI): A New Survey-Based Metric for Evaluating Innovation in Analytical Methods.Analytical chemistry · 2025Review
- Current Challenges in Microcapsule Designs and Microencapsulation Processes: A Review.ACS applied materials & interfaces · 2024Review
- Microplastics in Ecuador: A review of environmental and health-risk assessment challenges.Heliyon · 2024Review
- Plastic pollution: how can the global health community fight the growing problem?BMJ global health · 2023Article
- Training the next generation of plastics pollution researchers: tools, skills and career perspectives in an interdisciplinary and transdisciplinary field.Microplastics and nanoplastics · 2023Review
- Oxidation and fragmentation of plastics in a changing environment; from UV-radiation to biological degradation.The Science of the total environment · 2022Review
- A Children's Health Perspective on Nano- and Microplastics.Environmental health perspectives · 2022Article
- Confronting plastic pollution to protect environmental and public health.PLoS biology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Public concern over the environmental and public health impacts of the emerging contaminant class "microplastics" has recently prompted government agencies to consider mitigation efforts. Microplastics do not easily fit within traditional risk-based regulatory frameworks because their persistence and extreme diversity (of size, shape, and chemical properties associated with sorbed chemicals) result in high levels of uncertainty in hazard and exposure estimates. Due to these serious complexities, addressing microplastics' impacts requires open collaboration between scientists, regulators, and policymakers. Here we describe ongoing international mitigation efforts, with California as a case study, and draw lessons from a similarly diverse and environmentally persistent class of emerging contaminants (per- and polyfluoroalkyl substances) that is already disrupting traditional regulatory paradigms, discuss strategies to address challenges associated with developing health-protective regulations and policies related to microplastics, and suggest ways to maximize impacts of research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.